Myers R D, Swartzwelder H S, Peinado J M, Lee T F, Hepler J R, Denbow D M, Ferrer J M
Brain Res Bull. 1986 Oct;17(4):583-97. doi: 10.1016/0361-9230(86)90229-7.
The purpose of this investigation was to determine the functional relationship between putative satiety peptides and endogenous norepinephrine (NE) activity in the hypothalamus. Permanent guide cannulae for push-pull perfusion were implanted stereotaxically in Sprague-Dawley rats so as to rest above the medial or lateral hypothalamus (LH). Post-operatively, the animals were either satiated with food and water, both available ad lib, or fasted for 18-22 hr prior to an experiment. To perfuse a site in the LH, paraventricular (PVN) or ventromedial nucleus (VMN), a concentric 29-23 ga push-pull cannula system was lowered to a pre-determined site, in most cases after catecholamine stores had been pre-labeled with [3H]-NE. During control tests, an artificial CSF was perfused at a rate of 20-25 microliter/min for 5-8 min with a 5 min interval between each sample. The addition of cholecystokinin (CCK) in a concentration of 2.0-6.0 ng/microliter to the CSF perfused in PVN or VMN of the satiated rat enhanced the efflux of NE; however, in the fasted animal CCK often suppressed the catecholamine's release. Perfused in the LH, CCK exerted opposite effects, typically augmenting NE output when the rat was fasted but not affecting the amine's activity during the sated condition. Proglumide (1.2 micrograms/microliter) attenuated CCK's effect in releasing NE when the antagonist was perfused in the PVN of the satiated rat. Similar experiments in which neurotensin (NT) was perfused in the LH, PVN and VMN revealed virtually the same inverse effects on NE release in the fasted and satiated rat, which again were anatomically specific. Finally, insulin and 2-deoxy-D-glucose (2-DG) exerted similar state-dependent effects on the release of NE within LH and PVN. Overall, the results suggest that CCK or other neuroactive peptide could serve as a "neuromodulator" of the pre-synaptic release of NE within classical hypothalamic structures which are thought to underlie both hunger and satiety. The state-dependent nature of the peptides' activity on the noradrenergic feeding mechanism implies that these substances constitute a pivotal portion of the profile of factors which impinge functionally upon the hypothalamic neurons responsible for the feeding response and its cessation.
本研究的目的是确定假定的饱腹感肽与下丘脑内源性去甲肾上腺素(NE)活性之间的功能关系。将用于推挽灌注的永久性引导套管立体定位植入Sprague-Dawley大鼠体内,使其位于下丘脑内侧或外侧(LH)上方。术后,动物要么自由获取食物和水直至饱腹,要么在实验前禁食18 - 22小时。为了灌注LH、室旁核(PVN)或腹内侧核(VMN)中的某个部位,在大多数情况下,在儿茶酚胺储存已用[3H]-NE预先标记后,将一个同心的29 - 23号推挽套管系统降至预定部位。在对照试验期间,以20 - 25微升/分钟的速度灌注人工脑脊液5 - 8分钟,每个样本之间间隔5分钟。向饱腹大鼠的PVN或VMN中灌注的脑脊液中添加浓度为2.0 - 6.0纳克/微升的胆囊收缩素(CCK)可增强NE的流出;然而,在禁食动物中,CCK常常抑制儿茶酚胺的释放。在LH中灌注时,CCK产生相反的作用,通常在大鼠禁食时增加NE输出,但在饱腹状态下不影响胺的活性。当拮抗剂在饱腹大鼠的PVN中灌注时,丙谷胺(1.2微克/微升)减弱了CCK释放NE的作用。在LH、PVN和VMN中灌注神经降压素(NT)的类似实验显示,在禁食和饱腹大鼠中对NE释放几乎有相同的相反作用,而且这些作用在解剖学上具有特异性。最后,胰岛素和2 - 脱氧 - D - 葡萄糖(2 - DG)对LH和PVN内NE的释放产生类似的状态依赖性作用。总体而言,结果表明CCK或其他神经活性肽可作为经典下丘脑结构中NE突触前释放的“神经调节剂”,这些结构被认为是饥饿和饱腹感的基础。肽对去甲肾上腺素能进食机制的活性的状态依赖性性质意味着这些物质构成了在功能上影响负责进食反应及其停止的下丘脑神经元的一系列因素的关键部分。